Suitability of tumor-associated antibodies as predictive biomarker for response to immune checkpoint inhibitors in patients with melanoma: a short report

In 2019, Fässler et al showed in this journal that the presence of tumor-associated antibodies correlated with response to immune checkpoint inhibitor treatment in patients with metastatic melanoma. The results of this study suggested that tumor-associated antibodies directed against melanocyte-diff...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Ron H J Mathijssen, Reno Debets, Arjen Joosse, Astrid A M van der Veldt, Marco W J Schreurs, Sharon Veenbergen, Karlijn de Joode, Claudia Kransse, Dian Kortleve
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMJ Publishing Group 2023-02-01
Saila:	Journal for ImmunoTherapy of Cancer
Sarrera elektronikoa:	https://jitc.bmj.com/content/11/2/e006467.full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!